trimethobenzamide
Generic: TRIMETHOBENZAMIDE HYDROCHLORIDE·Brand: TIGAN, TRIMETHOBENZAMIDE HYDROCHLORIDE, TRIMETHOBENZAMIDE HYDROCHLORIDE PRESERVATIVE FREE
trimethobenzamide: 1 clinical trial tracked.
trimethobenzamide evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about trimethobenzamide, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
A Phase 4, Randomized, Open Label Study to Evaluate the Safety and Tolerability of Twice Daily Xanomeline/Trospium Chloride (KarXT) With Prophylactic and PRN Antiemetic Use in Healthy Volunteers
Primary endpoint: Number of participants with Treatment Emergent Adverse Events (TEAEs)
InterventionalRandomizedopen225 targetStarted 2026-09Completion 2026-114 sites · United StatesKaruna Therapeutics, Inc., a Bristol Myers Squibb company